NO20031922D0 - Faseoverföringskatalysert glykosidering av et indolkarbazol - Google Patents

Faseoverföringskatalysert glykosidering av et indolkarbazol

Info

Publication number
NO20031922D0
NO20031922D0 NO20031922A NO20031922A NO20031922D0 NO 20031922 D0 NO20031922 D0 NO 20031922D0 NO 20031922 A NO20031922 A NO 20031922A NO 20031922 A NO20031922 A NO 20031922A NO 20031922 D0 NO20031922 D0 NO 20031922D0
Authority
NO
Norway
Prior art keywords
indolcarbazole
phase transfer
transfer catalyzed
catalyzed glycosidation
glycosidation
Prior art date
Application number
NO20031922A
Other languages
English (en)
Other versions
NO20031922L (no
Inventor
Daniel E Petrillo
Steven A Weissman
Kai Rossen
Shouichi Hiraga
Nobuya Satake
Original Assignee
Banyu Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banyu Pharma Co Ltd filed Critical Banyu Pharma Co Ltd
Publication of NO20031922D0 publication Critical patent/NO20031922D0/no
Publication of NO20031922L publication Critical patent/NO20031922L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20031922A 2000-10-31 2003-04-29 Faseoverföringskatalysert glykosidering av en indolkarbazol NO20031922L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24467500P 2000-10-31 2000-10-31
PCT/US2001/047603 WO2002036601A2 (en) 2000-10-31 2001-10-26 Phase transfer catalyzed glycosidation of an indolocarbazole

Publications (2)

Publication Number Publication Date
NO20031922D0 true NO20031922D0 (no) 2003-04-29
NO20031922L NO20031922L (no) 2003-06-27

Family

ID=22923680

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031922A NO20031922L (no) 2000-10-31 2003-04-29 Faseoverföringskatalysert glykosidering av en indolkarbazol

Country Status (21)

Country Link
US (2) US6555677B2 (no)
EP (1) EP1333826A2 (no)
JP (1) JP3554560B2 (no)
KR (1) KR100813086B1 (no)
CN (1) CN1240380C (no)
AU (2) AU2894502A (no)
BG (1) BG107737A (no)
BR (1) BR0115036A (no)
CA (1) CA2426815A1 (no)
CZ (1) CZ20031209A3 (no)
EA (1) EA005209B1 (no)
HK (1) HK1064053A1 (no)
HU (1) HUP0302923A3 (no)
IL (1) IL155543A0 (no)
IS (1) IS6791A (no)
MX (1) MXPA03003871A (no)
NO (1) NO20031922L (no)
NZ (1) NZ525398A (no)
PL (1) PL365574A1 (no)
WO (1) WO2002036601A2 (no)
ZA (1) ZA200303198B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555677B2 (en) * 2000-10-31 2003-04-29 Merck & Co., Inc. Phase transfer catalyzed glycosidation of an indolocarbazole
RU2358979C2 (ru) 2003-05-30 2009-06-20 Фармассет, Инк. Модифицированные фторированные аналоги нуклеозида
CN1852914A (zh) * 2003-09-16 2006-10-25 万有制药株式会社 抗肿瘤性新型吲哚并吡咯并咔唑衍生物
EP1754711A4 (en) * 2004-05-28 2010-06-23 Banyu Pharma Co Ltd PROCESS FOR THE PREPARATION OF AN INDOLOPYRROLOCARBAZOLE DERIVATIVE
CN101023094B (zh) * 2004-07-21 2011-05-18 法莫赛特股份有限公司 烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
KR101177590B1 (ko) * 2004-09-14 2012-08-27 파마셋 인코포레이티드 2'-플루오로-2'-알킬 치환되거나 또는 다른 선택적으로치환된 리보퓨라노실 피리미딘 및 퓨린 및 그 유도체의제조
US7537774B2 (en) * 2005-12-23 2009-05-26 Orion Therapeautics, Llc Therapeutic formulation
US7964580B2 (en) 2007-03-30 2011-06-21 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs
US8173621B2 (en) * 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
US8551973B2 (en) 2008-12-23 2013-10-08 Gilead Pharmasset Llc Nucleoside analogs
KR20110104074A (ko) 2008-12-23 2011-09-21 파마셋 인코포레이티드 퓨린 뉴클레오시드의 합성
PA8855601A1 (es) 2008-12-23 2010-07-27 Forformidatos de nucleósidos
US8618076B2 (en) 2009-05-20 2013-12-31 Gilead Pharmasset Llc Nucleoside phosphoramidates
TWI583692B (zh) 2009-05-20 2017-05-21 基利法瑪席特有限責任公司 核苷磷醯胺
US8563530B2 (en) 2010-03-31 2013-10-22 Gilead Pharmassel LLC Purine nucleoside phosphoramidate
CA2794671C (en) 2010-03-31 2018-05-01 Gilead Pharmasset Llc Stereoselective synthesis of phosphorus containing actives
WO2012075140A1 (en) 2010-11-30 2012-06-07 Pharmasset, Inc. Compounds
US8889159B2 (en) 2011-11-29 2014-11-18 Gilead Pharmasset Llc Compositions and methods for treating hepatitis C virus
EP4005560A1 (en) 2013-08-27 2022-06-01 Gilead Pharmasset LLC Combination formulation of two antiviral compounds

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4808613A (en) 1986-11-21 1989-02-28 Bristol-Myers Company Rebeccamycin derivative containing pharmaceutical composition
GB8818430D0 (en) * 1988-08-03 1988-09-07 Tate & Lyle Plc Process
US5668271A (en) 1991-11-29 1997-09-16 Banyu Pharmaceutical Co., Ltd. Indolopyrrolocarbazole derivatives
US5437996A (en) 1992-11-24 1995-08-01 Banyu Pharmaceutical Co., Ltd. Microtetraspora strain for preparation of indolopyrrolocarbazole derivatives
US5591842A (en) 1991-11-29 1997-01-07 Banyu Pharmaceutical Co., Ltd. Indolopyrrolocarbazole derivatives
NZ245203A (en) 1991-11-29 1997-07-27 Banyu Pharma Co Ltd 5h-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6h)-dione derivatives substituted in position-13 by a pentose or hexose group; corresponding indolo-furano(anhydride)intermediates
US5589365A (en) 1991-11-29 1996-12-31 Banyu Pharmaceutical Co., Ltd. Process for producing glycosylated indolopyrrolocarbazole derivatives by culturing certain microorganisms
US5468872A (en) 1993-09-16 1995-11-21 Cephalon, Inc. K-252a functional derivatives potentiate neurotrophin-3 for the treatment of neurological disorders
CA2144940A1 (en) 1994-03-18 1995-09-19 Chikara Murakata Therapeutic agent for thrombocytopenia and indolocarbazole derivatives
US5804564A (en) 1994-05-09 1998-09-08 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyrrolocarbazole derivatives
US5922860A (en) * 1994-05-09 1999-07-13 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyrrolocarbazole derivatives
FR2750135B1 (fr) * 1996-06-20 1998-08-14 Ceca Sa Acides fluoroalkyl glycosides uroniques et lactones-6(3) correspondantes, preparation et utilisations
IL127918A0 (en) 1996-08-22 1999-11-30 Bristol Myers Squibb Co Novel amino sugar and related sugar derivatives of indolylopyrrolocarbazoles their use as antitumor agents and pharmaceutical formulations
US6555677B2 (en) * 2000-10-31 2003-04-29 Merck & Co., Inc. Phase transfer catalyzed glycosidation of an indolocarbazole

Also Published As

Publication number Publication date
IL155543A0 (en) 2003-11-23
WO2002036601A3 (en) 2002-11-28
AU2894502A (en) 2002-05-15
US20020058803A1 (en) 2002-05-16
WO2002036601A2 (en) 2002-05-10
US20040024196A1 (en) 2004-02-05
HUP0302923A2 (hu) 2003-12-29
IS6791A (is) 2003-04-16
BR0115036A (pt) 2004-02-25
PL365574A1 (en) 2005-01-10
KR100813086B1 (ko) 2008-03-17
EA200300525A1 (ru) 2003-08-28
BG107737A (bg) 2004-01-30
ZA200303198B (en) 2004-04-23
NO20031922L (no) 2003-06-27
HK1064053A1 (en) 2005-01-21
CZ20031209A3 (cs) 2003-10-15
EP1333826A2 (en) 2003-08-13
CN1482908A (zh) 2004-03-17
EA005209B1 (ru) 2004-12-30
NZ525398A (en) 2004-12-24
CN1240380C (zh) 2006-02-08
MXPA03003871A (es) 2003-07-28
JP3554560B2 (ja) 2004-08-18
US6555677B2 (en) 2003-04-29
AU2002228945B2 (en) 2006-02-02
HUP0302923A3 (en) 2005-02-28
CA2426815A1 (en) 2002-05-10
JP2004513131A (ja) 2004-04-30
KR20030082545A (ko) 2003-10-22

Similar Documents

Publication Publication Date Title
NO20031922D0 (no) Faseoverföringskatalysert glykosidering av et indolkarbazol
DE10085001T1 (de) Isolationstransformatoranordnung
NO20025517L (no) Triazolderivater
DE50007243D1 (de) Säschar
NO20032760D0 (no) Temperaturkompensert magnetisk krets
EE200300273A (et) Asendatud imidasopüridiinid
DK1139764T3 (da) Adjuvanssammensætning
EE200200150A (et) Preparaat
FI20000543A (fi) Siirtojärjestely
DE60032425D1 (de) Ätzvorrichtung
NO20015505L (no) Fremstilling av komplekse karbohydrater
DE60008994D1 (de) Isolationstransformatoren
DE60036701D1 (de) Temperaturkompensierter stabresonator
DE50103036D1 (de) O-substituierte 6-methyl-tramadol-derivate
DE29900640U1 (de) Duschabtrennung
PT9612T (pt) Banheira infantil
DE29905419U1 (de) Duschabtrennung
NO20022446L (no) Etere av O-desmetyl-venlafaxine
DE59909327D1 (de) Ringkern
FI20002248A0 (fi) Eristysmoduli
NO981778D0 (no) Isolasjonsanordning
HK1061643A1 (en) Phase transfer of naoparticles
DK1227795T3 (da) Lipidkompleks af alkycycliner
UA3344S (uk) Газоперекачувальний агрегат
DE50010689D1 (de) Duschabtrennung

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application